AVR

Anteris Technologies Global Corp. Health Care Orthopedic, Prosthetic & Surgical Appliances & Supplies Russell 3000

$6.31Close $262.4MMarket cap $3.38 – $10.5752-week range Nov 11, 2026Next report

Highlights

Cautions

Not in an uptrend 3 of 8 trend conditions
Lagging the market RS 43 · weaker than 57% of stocks over 12 months
Far from its high 40% below its 52-week high
Results soon Nov 11, 2026, in 10 days
Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 11, 2026

Off 12-month high 40%

1wk 7.5% price change

1mo 18.8% price change

12-month return 46% market up 11% · its own up 33%

F-score — — Not assessed

Altman Z -29.47 Elevated risk

P/E — price / earnings

PEG — P/E / EPS growth

P/B — price / book

Earnings yield 36.7% EBIT / enterprise value

Cheaper than — of the market · not assessed

Revenue growth 29% year on year

EPS growth — latest quarter

Sales growth 63% latest quarter · +74 pts

ROE — return on equity

Free cash margin 4169% -$79.8M FCF

D/E — long-term debt / equity

Net debt / EBITDA —

Interest cover Lossoperating loss

Piotroski tests

Repair signals

Gross margin 46.8% → 70.3%

Trade setup

ATR% 5.1% $0.32 a day · 2×ATR $5.67

RS 43 / 99 vs the universe

Trend 3 / 8 trend template

Relative volume 1.3× vs 50-day average

Up/down volume 0.69 50 sessions

Implied move — no option chain · report Nov 11, 2026

Trend template · 3 of 8

Price above the 150 and 200-day averages: fails
150-day average above the 200-day: passes
200-day average rising for a month: passes
50-day average above the 150 and 200-day: fails
Price above the 50-day average: fails
At least 30% above the 52-week low: passes
Within 25% of the 52-week high: fails
RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

5 flagged

Liabilities exceed assets Shareholders' equity is negative at -$93,000 as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
Shareholders diluted The share count rose 15.7% over the year, from 36m to 42m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Revenue shrinking Revenue fell 29.2% over the year, from $2.7M to $1.9M.

Last reported Aug 12, 2026

Results reaction Aug 12, 2026-4% vs market2 sessions after results

Financials

2 fiscal years · from filings

Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.9M -29% on FY2024

Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$94.1M

Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$79.8M

Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology

Gross 70%
Net -4921%
Free cash -4169%

Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $6.7M net cash

Cash
Long-term debt

Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 41.58m +15.7% since FY2024

	FY2024Dec 31, 2024	FY2025Dec 31, 2025
Revenue	$2.7M	$1.9M
Gross margin	47%	70%
Operating income	-$78.4M	-$93.9M
Net income	-$76.3M	-$94.1M
Net margin	-2822%	-4921%
Earnings per share	-$3.77	-$2.55
Free cash flow	-$63.5M	-$79.8M
Free cash margin	-2350%	-4169%
Cash	$70.5M	$6.7M
Long-term debt	$0	$22,000
Shareholders' equity	$62.8M	-$93,000
Shares outstanding	35.94m	41.58m

Filings

SEC EDGAR

Filed	Report	Period to	Lag
Aug 11, 2026	Quarterly ↗	Jun 30, 2026	42d
May 12, 2026	Quarterly ↗	Mar 31, 2026	42d
Feb 26, 2026	Annual ↗	Dec 31, 2025	57d
Nov 12, 2025	Quarterly ↗	Sep 30, 2025	43d
Aug 11, 2025	Quarterly ↗	Jun 30, 2025	42d
May 13, 2025	Quarterly ↗	Mar 31, 2025	43d

Current reports

Filed	Disclosed
Sep 23, 2026	Material agreement ↗
Sep 17, 2026	Director or officer change ↗
Sep 8, 2026	Director or officer change ↗
Aug 12, 2026	Results ↗
Aug 3, 2026	Regulation FD ↗
Jul 31, 2026	Regulation FD ↗
May 22, 2026	Material agreement ↗
May 13, 2026	Director or officer change ↗
May 13, 2026	Results ↗
Apr 29, 2026	Agreement ended ↗
Apr 23, 2026	Material agreement ↗
Mar 3, 2026	Director or officer change ↗